March 24, 2025

Trump Aligned Think Tank Wants Drug Price Reductions

America First Policy Institute (AFPI), a conservative think tank friendly with Donald Trump, says the administration should bring back Trump 45’s international reference pricing policy for drugs across federal health programs and in the commercial market. So far, the Trump administration has firmly backed the Medicare drug price law.

The think tank says there are many ways the pricing could be implemented, including via the drug law. The push for commercial application is watershed. AFPI also recommends the Trump administration restrict drug makers’ ability to charge lower prices internationally than in America and use its trade negotiation power to press countries to stop using so-called “freeloading” policies.

(Article may require a subscription.)

#drugpricing #trump #ira #branddrugmakers

https://insidehealthpolicy.com/inside-drug-pricing-daily-news/trump-aligned-think-tank-calls-admin-bring-back-mfn-policy

Surprise Nomination For CDC Director

In a surprise, Donald Trump announced that he will nominate Susan Monarez to lead the Centers for Disease Control and Prevention. Monarez is currently acting director at the CDC. Before that, she was deputy director of ARPA-H, a federal agency created during the Biden administration that set out to fund innovative biomedical research. It was thought that former Rep. Michael Burgess, M.D., was the leading contender for the post.

 Additional articles: https://www.fiercehealthcare.com/regulatory/white-house-nominating-susan-monarez-cdc-director-reports and https://www.modernhealthcare.com/politics-policy/trump-cdc-susan-monarez and https://www.medpagetoday.com/washington-watch/washington-watch/114796 and https://www.beckershospitalreview.com/hospital-management-administration/president-trump-nominates-cdc-director-4-things-to-know/

(Some articles may require a subscription.)

#trump #healthcare #cdc #hhs

https://thehill.com/policy/healthcare/5211581-trump-picks-new-cdc-nominee-acting-director-susan-monarez/?tbref=hp

J & J To Invest More In America

Post a meeting a few weeks back with Donald Trump, Johnson & Johnson announced on Friday that it will invest $55 billion in U.S. manufacturing, research and development, and technology over the next four years. This is a 25% increase compared with the past four years.

(Article may require a subscription.)

#branddrugmakers #drugpricing #trump

https://www.modernhealthcare.com/digital-health/johnson-johnson-us-manufacturing

Part D Membership Ranked

Becker’s ranks enrollment in the standalone Part D program. Centene leads the nation.

#partd #pdp #medicare #cms

https://www.beckerspayer.com/uncategorized/payers-ranked-by-part-d-membership-2025

KFF Primers On Potential Cuts

As Congress readies to make major cuts to the federal budget, healthcare policy group KFF has issued a briefer on how Medicare pays physicians as well the potential Medicaid cuts on state budgets. Medicare docs are badly in need of a permanent fix and reversal of a 2.8% reduction for 2025.

Additional article: https://www.kff.org/medicare/issue-brief/what-to-know-about-how-medicare-pays-physicians/

#physicians #medicare #medicaid #budgetreconciliation

https://www.kff.org/medicaid/issue-brief/putting-880-billion-in-potential-federal-medicaid-cuts-in-context-of-state-budgets-and-coverage/

— Marc S. Ryan

Leave a Reply

Your email address will not be published. Required fields are marked *

Available Now

$30.00